Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-000657

Options or other derivatives

  • Director acquired 62,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
GROGAN DONNA ROY Director 2026-06-24 Grant or award · Stock Option (Right to Buy) +62,000 62,000 D: show line 1 in the form
Loading xslF345X06/wk-form4_1782505541.xml…